METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN

2016 ◽  
Vol 22 (5) ◽  
pp. 575-586 ◽  
Author(s):  
Harriette Mogul ◽  
Ruth Freeman ◽  
Khoa Nguyen
Keyword(s):  
Insulin Resistance ◽  
Weight Loss ◽  
Weight Gain ◽  
Randomized Trial ◽  
Metabolic Profile ◽  
Fat Tissue ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Sustained Weight Loss ◽  
Android Fat

scholarly journals Metformin for Prevention of Weight Gain and Insulin Resistance with Olanzapine: A Double-Blind Placebo-Controlled Trial

2006 ◽  
Vol 51 (3) ◽  
pp. 192-196 ◽  
Author(s):  
Trino Baptista ◽  
Jessan Martínez ◽  
Anny Lacruz ◽  
Nairy Rangel ◽  
Serge Beaulieu ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Weight Gain ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial

2004 ◽  
Vol 30 (3) ◽  
pp. 253-258 ◽  
Author(s):  
F Guerrero-Romero ◽  
HE Tamez-Perez ◽  
G González-González ◽  
AM Salinas-Martínez ◽  
J Montes-Villarreal ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Insulin Sensitivity ◽  
Randomized Trial ◽  
Magnesium Supplementation ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Oral Magnesium

scholarly journals A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial

2017 ◽  
Vol 28 (8) ◽  
pp. 1957-1963 ◽  
Author(s):  
A. Jatoi ◽  
P.D. Steen ◽  
P.J. Atherton ◽  
D.F. Moore ◽  
K.M. Rowland ◽  
...  
Keyword(s):  
Weight Loss ◽  
Randomized Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Cancer Anorexia
Sign in / Sign up

Export Citation Format

Share Document